Owned and operated by Baba Kahn, a CF veteran 
Independent analytical report
BPC-157 / TB-500 20 mg — Task 103190
Review the report details, original PDF and Janoshik verification record.
Report summary
- Compound
- BPC-157 / TB-500
- Strength
- 20 mg
- Tested quantity
- BPC-157 10.56 mg, TB-500 10.79 mg
- Report date
- January 29, 2026
- Janoshik task ID
- #103190
The earlier of two analytical records for the 20 mg BPC-157 / TB-500 blend. The vial was submitted in January 2026 under the sample name “Project X 20mg (BPC/TB combo)”, received by Janoshik on 27 January and analysed on 29 January. The laboratory reported 10.56 mg of BPC-157 and 10.79 mg of TB-500 (TB4).
It was ordered as a general assessment of a peptide vial, the standard approach for submissions in this period, and the certificate lists Peptide Factory Canada, Red Leaf’s sister brand, as the submitting client. Like the September 2026 analysis, it reports quantities only, with no purity figure. It stays published as report history rather than being replaced.
This certificate describes the submitted sample identified in the report. It does not establish clinical safety, efficacy, suitability for human or veterinary use, or the specifications of future inventory.
